Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Overweight on Anheuser-Busch InBev, Raises Price Target to $73

Author: Benzinga Newsdesk | September 10, 2024 08:50am
Morgan Stanley analyst Sarah Simon maintains Anheuser-Busch InBev (NYSE:BUD) with a Overweight and raises the price target from $68.5 to $73.

Posted In: BUD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist